Pharma & Biotech

The future of Tübingen-based biotech firm CureVac hangs in the balance as the company approaches a critical juncture. With operational...

Stereotaxis shares gained 3.57% on Friday, closing at $2.32, but the real market-moving event arrives next week. Chief Executive Officer...

Xoma Royalty shares demonstrated positive momentum at the week's opening, trading at $32.14 and marking a nearly 1 percent gain....

After an extended period of decline, Pfizer's shares are attracting renewed attention from Wall Street. A powerful combination of regulatory...

Assembly Biosciences shares are demonstrating remarkable upward momentum, closing out the week with significant strength and positioning themselves for a...

Redcare Pharmacy stock is experiencing a severe downturn, reaching its lowest point in the past year. The share price has...

Sarepta Therapeutics finds itself navigating significant regulatory challenges as the U.S. Food and Drug Administration has imposed the most serious...

Recent SEC filings have unveiled a dramatic divergence in strategy among major investment firms regarding biotechnology company Incyte. While several...

Shares of Abbott Laboratories experienced significant volatility following the announcement of a major acquisition in the cancer diagnostics sector. The...

The investment case for Danish pharmaceutical giant Novo Nordisk appears to be in tatters as 2025 unfolds, with its equity...